Atrandi Biosciences
PrivateLast Round
Series A
Feb 19, 2025
Total Funding Raised
$31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atrandi Biosciences operates in Healthcare & Life Sciences and is based in Vilnius. Its latest recorded funding round was a Series A round in February 2025.
Atrandi Biosciences is a biotechnology company that develops next-generation single-cell analysis technology, including microfluidic platforms and semi-permeable capsule (SPC) solutions for life sciences research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atrandi Biosciences Comparables
Compare Atrandi Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singleron Biotechnologies | 81% | |
| Mission Bio | 80% | |
| BioSkryb Genomics | 78% |
For institutional investors. Book with your work email.
Atrandi Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 19, 2025 | ||||
| Seed | Mar 23, 2023 | ||||
| Seed | Jan 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Atrandi Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Series A, Seed |
| Practica Capital | Series A, Seed |
| Lux Capital | Series A |
| Vsquared Ventures | Series A, Seed |
| GRIDS Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 49% MoM to 3.6K.
- Jul 20, 2026
Open roles increased to 36, representing 46% of headcount.
For institutional investors. Book with your work email.
Atrandi Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atrandi Biosciences's valuation, stock price, and market status.
Is Atrandi Biosciences a public or private company?
Atrandi Biosciences is a private company.
What is the current stock price of Atrandi Biosciences?
Atrandi Biosciences is a private company, so its shares have no public market price. Caplight tracks Atrandi Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atrandi Biosciences worth (valuation)?
Valuation information for Atrandi Biosciences is not publicly available.
Can I buy Atrandi Biosciences stock?
Atrandi Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atrandi Biosciences's last funding round?
Atrandi Biosciences's most recent funding round was Series A on February 19, 2025.
Who are the main investors in Atrandi Biosciences?
Key investors in Atrandi Biosciences include Practica Capital, Lux Capital, Vsquared Ventures.
Will Atrandi Biosciences IPO soon?
No public IPO plans have been announced for Atrandi Biosciences.
How can I track Atrandi Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Atrandi Biosciences's shares on secondary markets.